The Yin and the Yang of Treatment for Chronic Hepatitis B—When to Start, When to Stop Nucleos(t)ide Analogue Therapy

Over 257 million individuals worldwide are chronically infected with the Hepatitis B Virus (HBV). Nucleos(t)ide analogues (NAs) are the first-line treatment option for most patients. Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are both potent, safe antiviral agents, have a high barrier t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Samuel, Howell, Jessica, Visvanathan, Kumar, Thompson, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552074/
https://www.ncbi.nlm.nih.gov/pubmed/32854335
http://dx.doi.org/10.3390/v12090934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552074/
https://www.ncbi.nlm.nih.gov/pubmed/32854335
http://dx.doi.org/10.3390/v12090934

Ejemplares similares